Boardroom Alpha
Boardroom Alpha
LEG · Current Report (Form 8-K) · Filed August 21, 2026

Leggett & Platt Inc — Current Report (Form 8-K)

Form
8-K
Filed
August 21, 2026
Period
Aug 20, 2026
Ticker
LEG
Accession
0001193125-26-361156
Boardroom Alpha · Filing insights

Leggett & Platt shareholders approved the Merger with Somnigroup and related merger-related executive compensation at the August 2026 meeting.

About Leggett & Platt Inc
Market cap
$1.3B
1Y TSR
+8.3%
3Y TSR
−27.7%
Board grade
D
Sector
Consumer Cyclical
CEO
Karl G Glassman
Last annual meeting: May 21, 2026 · View full Leggett & Platt Inc profile →
FORM 8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) August 20, 2026

 

 

LEGGETT & PLATT, INCORPORATED

(Exact name of registrant as specified in its charter)

 

 

 

Missouri   001-07845   44-0324630

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

1 Leggett Road  
Carthage, MO   64836
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code 417-358-8131

N/A

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Common Stock, $.01 par value   LEG   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange

 

 
 


Item 5.07

Submission of Matters to a Vote of Security Holders.

As previously disclosed, Leggett & Platt, Incorporated, a Missouri corporation (the “Company”) entered into an Agreement and Plan of Merger, dated April 13, 2026 (the “Merger Agreement”), by and among Somnigroup International Inc., a Delaware corporation (“Parent”), and Sparrow Unity Corporation, a Missouri corporation and a direct, wholly owned subsidiary of Parent (“Merger Sub”). Pursuant to the terms of the Merger Agreement, Merger Sub will merge with and into the Company (the “Merger”), with the Company continuing as the surviving corporation of the Merger and as a direct, wholly owned subsidiary of Parent. On August 20, 2026, the Company held a special meeting of shareholders (the “Special Meeting”) to consider certain proposals relating to the Merger Agreement. Such proposals are described in more detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on July 9, 2026.

As of the close of business on July 6, 2026, the record date for the Special Meeting (the “Record Date”), there were 136,578,715 shares of common stock, par value $0.01 per share, of the Company (“Company common stock”) outstanding, each of which was entitled to one vote on each proposal at the Special Meeting. At the Special Meeting, a total of 109,747,006 shares of Company common stock, representing approximately 80.35% of the outstanding shares of Company common stock entitled to vote, were present in person or represented by proxy, constituting a quorum to conduct business.

The number of votes cast for and against, as well as abstention votes, with respect to each proposal presented at the Special Meeting was as follows:

Proposal No. 1: Approval of the Merger Agreement

The Company’s shareholders approved the proposal to adopt the Merger Agreement and thereby approve the transactions contemplated by the Merger Agreement, including the Merger, as follows:

 

FOR

 

AGAINST

 

ABSTAIN

102,234,833   7,364,123   148,050

Proposal No. 2: Advisory Vote on Merger-Related Named Executive Officer Compensation

The Company’s shareholders approved, on a non-binding, advisory basis, certain compensation that will or may become payable to the Company’s named executive officers in connection with the Merger as follows:

 

FOR

 

AGAINST

 

ABSTAIN

100,258,757   8,988,480   499,769

Proposal No. 3: Adjournment of the Special Meeting

The Company’s shareholders approved the proposal to adjourn the Special Meeting, if necessary, to solicit additional proxies to adopt the Merger Agreement or to allow reasonable additional time for the filing and mailing of any required supplement or amendment to the proxy statement/prospectus, and the review of such materials by Company shareholders as follows:

 

FOR

 

AGAINST

 

ABSTAIN

98,103,626   10,909,534   733,846

 

 

2


However, because Proposal No. 1 to adopt the Merger Agreement was approved and no supplement or amendment to the proxy statement/prospectus was necessary, the adjournment of the Special Meeting was not necessary and, accordingly, the Special Meeting was not adjourned.

 

Item 7.01

Regulation FD Disclosure.

On August 20, 2026, the Company issued a press release announcing shareholder approval of the Merger Agreement and the transactions contemplated by the Merger Agreement. A copy of the press release is attached hereto as Exhibit 99.1 to this Current Report and is incorporated herein by reference.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits.

EXHIBIT INDEX

 

Exhibit
No.
  

Description

99.1*    Press Release dated August 20, 2026
104    Cover Page Interactive Data File (embedded within the inline XBRL document)

 

*

Denotes furnished herewith.

 

 

3


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    LEGGETT & PLATT, INCORPORATED
Date: August 21, 2026     By:  

/s/ Jennifer J. Davis

      Jennifer J. Davis
      Executive Vice President – General Counsel

 

4

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Leggett & Platt Inc (LEG)

Reference

Frequently asked questions

When did Leggett & Platt Inc file this 8-K?
Leggett & Platt Inc (LEG) filed this Current Report (Form 8-K) with the SEC on August 21, 2026. The accession number assigned by EDGAR is 0001193125-26-361156.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Leggett & Platt shareholders approved the Merger with Somnigroup and related merger-related executive compensation at the August 2026 meeting. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Leggett & Platt Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Leggett & Platt Inc has filed under CIK 58492, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer